Lamotrigine

In the US, Lamotrigine (lamotrigine systemic) is a member of the drug class triazine anticonvulsants and is used to treat Anxiety, Bipolar Disorder, Borderline Personality Disorder, Cyclothymic Disorder, Depression, Migraine Prevention, Post Traumatic Stress Disorder, Restless Legs Syndrome, Schizoaffective Disorder and Seizure Prevention.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N03AX09

CAS registry number (Chemical Abstracts Service)

0084057-84-1

Chemical Formula

C9-H7-Cl2-N5

Molecular Weight

256

Therapeutic Category

Antiepileptic agent

Chemical Name

1,2,4-Triazine-3,5-diamine,6-(2,3-dichlorophenyl)-

Foreign Names

  • Lamotriginum (Latin)
  • Lamotrigine (German)
  • Lamotrigine (French)
  • Lamotrigina (Spanish)

Generic Names

  • Lamotrigine (OS: BAN, DCF, USAN)
  • BW 430 C (IS: Wellcome)
  • Lamotrigine (PH: BP 2011, Ph. Eur. 7, USP 34)
  • Lamotriginum (PH: Ph. Eur. 7)

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web1)